Skip to main content

Table 2 Drug resistance patterns of Mycobacterium tuberculosis isolates

From: Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya

Category New cases Retreatment cases All cases
N (%) 95 % CI N (%) 95 % CI N (%) 95 % CI
Total patients N = 160   N = 24   N = 184  
Any Resistance 56 (35 %) 27.61–42.39 5 (20.8) 4.56–37.04 61 (33.1) 26.3–39.3
Any Resistance to:
 STR 10 (6.25) 2.5–10.0 3 (12.5) 0.73–25.73 13 (7.1) 3.39–10.81
 INH 40 (25) 18.29–31.71 4 (20) 4.0–36.0 44 (23.9) 17.74–30.06
 RIF 10 (6.25) 2.5–10.0 2 (8.3) 2.74–19.34 12 (6.5) 2.94–10.06
 EMB 21 (13) 7.87–18.33 4 (16.7) 1.78–31.62 25 (13.6) 8.65–18.55
Mono Resistance to
 STR 4 (2.5) 0.08–4. 92 0 (0) - 4 (2.2) 0.08–4.32
 INH 25 (15.6) 9.98–21.22 0 (0) - 25 (13.6) 8.65–18.55
 RIF 1 (0.63) 0.6–1.86 0 (0) - 1 (0.5) 0.52–1.52
 EMB 10 (6.25) 2.5–10.0 1 (4.16) 3.83–12.15 11 (6.0) 2.57–9.43
INH + RIF Resistant (MDR)
 INH + RIF only 4 (2.5) 0.08–4.92 0 (0) - 4 (2.2) 0.08–4.32
 INH + RIF + EMB 1 (0.63) 0.6–1.86 0 (0) - 1 (0.5) 0.52–1.52
 INH + RIF + STR 0 (0)   0 (0) - 0 (0) -
 INH + RIF + EMB + STR 2 (1.25) 0.47–2.97 2 (8.3) 2.74–19.34 4 (2.2) 0.08–4.32
 Total MDR 7 (4.4) 1.22–7.58 2 (8.3) 2.74–19.34 9 (4.9) 1.78–8.02
INH + other Resistance
 INH + STR 3 (1.9) 0.22–4.02 1 (4.16) 3.83–12.15 4 (2.2) 0.08–4.32
 INH + EMB 5 (3.1) 0.41–5.79 1 (4.16) 3.83–12.15 6 (3.3) 0.72–5.88
 INH + STR + EMB 1 (0.63) 0.6–1.86 0 (0) - 1 (0.5) 0.52–1.52
RIF + other Resistance
 RIF + EMB 1 (0.63) 0.6–1.86 0 (0) - 1 (0.5) 0.52–1.52
 RIF + STR + EMB 1 (0.63) 0.6–1.86 0 (0) - 1 (0.5) 0.52–1.52